On August 30, 2022, Hologic, Inc. announced that Sean S. Daugherty, the Company's Group President, Breast/Skeletal Health and GYN Surgical Solutions, will be separating from the Company, as of September 30, 2022. It is anticipated that Mr. Daugherty will continue to provide consulting services to the Company for a short duration after the Transition Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.81 USD | +1.69% | +0.01% | +3.30% |
May. 29 | Transcript : Hologic, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 10:00 AM | |
May. 22 | FDA classifies recall of Hologic's implant as 'most serious' | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.30% | 17.23B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Announces Separation of Sean S. Daugherty as President, Effective September 30, 2022